• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/17

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

17 Cards in this Set

  • Front
  • Back

Case I

ddx viral hep, cellulities, choleangitits


tests; ultrasound


rx; cholestryamine for the itch and excess bile salts, then naltrexone for itch and IV sedation



Incidence of DILI

most drugs exhibit a low incidence of liver injury



4-8% of patients hopsitalized for jaundice had DILI



leading cause of acute liver failure referred for transplantation



Hepatic drug metabolism

Phase 1 increase the solubility via addition of polar head groups, mainly by cytochrome p450 superfamily of MFOs CYP 1-3



Phase 2 conjugation to a large polar group, glucaronic acid, sulfate, acetate, glutathione



Phase 3; transport into bile, ATP depedent transporters in the bile canaliculi

Factors affects phase 1-3 rxns

diet; induction or inhbition of CYP enzymes by foods, chronic alcohol increase CYP2E1 and depletes glutathione



presence of other drugs



age; infants have immaturity of CPY eznymes, decrease in CYP with aging, age relating differences in phase 2 rxns



genetics; SNPs, fast and slow acetylators, gilbert syndrome with diminished capacity for glucrondination is linked to irnotectan tox



underlying liver disease

Case 2

increased UC meds, was terrible UC, started steroids which slight improved, wanted to use anti-TNF antibodies but had latent Tb, treated on isoniazid for the latent Tb



at 6 weeks the aminotransferases rose to 2x normal, but continued to watch

Types of DILI

predicted; occur in most people after a threshold dose is reached, dose related, latent period between exposure and reaction is brief, acetaminophen



unpredictable; unrelated to dose, latency period of a few days to 12 month, may or may not be due to hypersensitivity or immunology injury

Mechanisms of DILI injury

intrinsic = necrosis of hepatocytes



idiosyncratic = necrotic or cholestatic, can be hypersensitive or hyposensititve

Patterns of injury

hepatocellular = elevated ALT



mixed = elevated ALP an ALT



cholestatic = Elevated ALP and TBL

Common histo features

microvesicular fat



acute hep



cholestasis



eosinophilic rich infiltrate

Case 3

NSAID used for arthritis

Herbals and Hepatic injury

little monitoring, minimal recording, not often reported by the patient because they do not realize their potentil potency

Etiology of liver failure

acetaminophen, other drugs, then Hep B then A

Acetaminophen metabolism

at therapeutic doses, 90% conjugated with sulfate or glucuronide and excreted in urine,



but remainder is metabolized in the CYP450 pathway to N acetyl p benzoquineoneimine



but if you have reduced glutathione due to other conjugation the toxic metabolite and overpopulate

acetaminophen toxicity

with toxic doses, sulfation and glucuronidation pathways are saturated and more is metabolized to NAPQI



reduced stores in teh chronically ill, starved, and alcoholics



effects the hepatocytes around the central vein where the clotting factors arise

factors influencing tox

excessive intake, CYP activity, decreased glucuronidation or sulfation, depletion of glutathione stores

Rumack-Matthew normogram

single acute overdose of an immediate release prep of acetaminophen at 4 to 24 hrs after ingestion



sustained prep measure at 4 and 8 hrs



chronic overdose, serum levels may be normal

Rx for acetaminophen poisoning

activated charcoal within 4hrs of ingestion to decrease absorption



acetylcysteine for those with a risk for of hepatotoxicity, (glutathione derivative) restores levels



given orally and IV, liver transplantaiton for those with progressive liver failure